The outlook for Organon (OGN) appears positive, with financial analysts forecasting a significant potential upside based on their twelve-month price targets.
Based on the analysis from four financial analysts, Organon currently has an average price target that suggests a substantial increase from its current trading price. This collective view points towards a favorable future performance for the stock in the short to medium term.
Analyst Price Targets for Organon (OGN)
Analyst price targets provide a forward-looking assessment of a stock's potential value, offering insights into market expectations. For Organon, the consensus among analysts indicates a healthy growth projection.
Here's a breakdown of the recent analyst price targets for Organon:
| Metric | Value |
|---|---|
| Number of Analysts | 4 |
| Current Price | $14.58 |
| Average Price Target | $21.33 |
| Highest Price Target | $24.00 |
| Lowest Price Target | $20.00 |
| Forecasted Upside | 46.32% |
The average price target of $21.33 for Organon represents a forecasted upside of 46.32% from its current price of $14.58. This substantial percentage indicates a strong belief among analysts in the company's potential to grow its market valuation over the next twelve months. While there is a range in individual analyst predictions, with targets varying from $20.00 to $24.00, the overall sentiment remains optimistic.
This positive outlook suggests that analysts expect Organon's business fundamentals, strategic initiatives, or market conditions to support a significant increase in its stock price.
